Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A federal advisory panel strongly supported a bid for Novavax to win US emergency authorization for its COVID-19 vaccine, which is based on a more traditional, protein-based approach than the cutting-edge technology used in mRNA-based shots. The Vaccines and Related Biological […]
Category Archives: Articles
Individuals with obesity were at least two times more likely to develop certain types of cancer and 3.5 times more likely to die from the disease than those who had weight-loss surgery, according to a new study presented here today at the American Society for Metabolic and Bariatric Surgery (ASMBS) Annual Meeting (#ASMBS2022). Researchers found […]
Social engagement such as participation in community or school-based activities may mitigate psychosis risk in susceptible youth living in disadvantaged communities, new research suggests. A study of more than 170 young participants showed reduced hippocampal volume in those living in poor neighborhoods who had low social engagement vs their peers with greater community engagement. Dr […]
In a recent study posted to the medRxiv* preprint server, researchers evaluated associations between physical activity and long coronavirus disease (COVID) symptoms. Study: Symptom variation, correlations, and relationship to physical activity in Long Covid: intensive longitudinal study. Image Credit: Donkeyworx / Shutterstock Background Post-acute sequelae of COVID 2019 (COVID-19) (PASC), long COVID, or post-COVID syndrome […]
Another glucagon-like peptide-1 (GLP1) agonist, dulaglutide (Trulicity, Lilly), is poised to be a new option for glycemic control in youth ages 10 to 18 with type 2 diabetes, given as a weekly injection, based on the AWARD -PEDS clinical trial. The US Food and Drug Administration (FDA) has already approved daily injection liraglutide (Victoza, Novo […]
In a study of patients with high-risk renal cell carcinoma, those who took the drug everolimus daily for up to one year after surgery lived longer without their disease returning (recurrence-free survival, or RFS) than those who did not take everolimus, although the results narrowly missed the clinical trial’s prespecified level for statistical significance. Improvement […]
Trauma surgeons are in the tough position of seeing victims just after gun violence across the United States, and they have some advice. Their strategies can work regardless of where you stand on the Second Amendment of the Constitution, said Patricia Turner, MD. “Our proposals are embraced by both gun owners and non-gun owners alike, […]
Differences in behavior among people with Autism Spectrum Disorder (ASD) are closely related to differences in neuroanatomy – the shape of a brain – a team of Boston College neuroscientists report today in the journal Science. This discovery could help to understand the causes of ASD, and to develop personalized interventions. The team used artificial […]
If you’ve spent any time at all learning about marketing, hopefully one thing that has jumped out to you is the focus of video marketing. It makes sense. We all carry in our pockets everything we need to create, edit, and publish our own video content. Prior to the smartphone, the cost of producing and […]
COPENHAGEN — The Janus kinase (JAK) inhibitor upadacitinib (Rinvoq, AbbVie) was associated with significant improvements in disease activity, pain, function, and quality of life compared with placebo in patients with nonradiographic axial spondyloarthritis (nr-axSpA), results of the first efficacy analysis of the phase 3 randomized SELECT-AXIS-2 trial showed. The trial met its primary endpoint of […]